The government looses money from pandemics, so there’s no profit motive for FDA regulators to prolong the pandemic. There’s both direct costs of coronavirus response, and then there’s indirect costs (lower tax revenue from empty downtowns, less travel, more workers on taking from disability insurance instead of paying in to it, etc).